The emerging research on the role of immune responses in neuroinflammatory diseases such as MS highlights a complex interplay between various T cell subsets, including Th1, Th17, Th2, and Treg cells, as well as the involvement of B cells and CD8+ T cells. Here, CD8A is linked to myeloid sarcoma.